6-KThe Wire
TAKEDA PHARMACEUTICAL CO LTD files 6-K
Filed May 19, 2026 · 1mo ago · Accession 0001395064-26-000149
Plain English
Takeda announced a jury verdict awarding plaintiffs USD 884,943,990 in single damages in the AMITIZA antitrust litigation, which will be automatically trebled for certain classes. The company will revise its FY2025 financial results to reflect a provision for this matter.
Filing details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Ticker
- TAK
- CIK
- 1395064
- Form type
- 6-K
- Filing date
- May 19, 2026
- Report date
- May 19, 2026
- Document
- form6k_051926.htm
- Size
- 31 KB